The Institute of Environmental Science and Research (ESR) has changed its name to the New Zealand Institute for Public Health and Forensic Science (PHF Science) as of 1 July 2025. The website address is now www.phfscience.nz. Visitors are automatically redirected to the new address. Please check and update any links and bookmarks.
Use our research, insights & resources
Our intelligence hub hosts all our information, from disease surveillance dashboards to environmental risk assessments. Explore and use PHF Science’s research, insights, tools and resources to make a difference for Aotearoa New Zealand.
PHF Science is working to actively co-design with Māori in research, science and innovation to improve Māori economic, social and wellbeing outcomes and impacts.
PHF Science is a New Zealand Government owned research organisation that plays a critical national role in public health and forensics, and is a key contributor to environment and biosecurity outcomes.
Staphylococcus aureus 'Down Under': contemporary epidemiology of S. aureus in Australia, New Zealand, and the South West Pacific
Abstract
The clinical and molecular epidemiology of Staphylococcus aureus disease has changed considerably over the past two decades, particularly with the emergence and spread of community-associated methicillin-resistant S. aureus (CA-MRSA) clones. Indeed, some of the first global descriptions of CA-MRSA were from remote indigenous communities in Western Australia, and from Pacific Peoples in New Zealand. The epidemiology of S. aureus infections in the South West Pacific has several unique features, largely because of the relative geographical isolation and unique indigenous communities residing in this region. In particular, a number of distinct CA-MRSA clones circulate in Australia and New Zealand, such as sequence type (ST) 93 methicillin-resistant S. aureus (MRSA) (Queensland clone) and clonal complex 75 S. aureus (Staphylococcus argenteus) in Australia, and ST30 MRSA (Southwest Pacific clone) in New Zealand. In addition, there is a disproportionate burden of S. aureus disease in indigenous paediatric populations, particularly in remote Aboriginal communities in Australia, and in Pacific Peoples and Maori in New Zealand. In this review, we provide a contemporary overview of the clinical and molecular epidemiology of S. aureus disease in the South West Pacific region, with a particular focus on features distinct to this region.
